APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target is a research paper published in NAR Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA225637
National Cancer Institute
Grant: R03CA270663
National Cancer Institute
Grant: R01CA251141
National Institutes of Environmental Health Sciences of the National Institutes of Health
Grant: R21ES032966
National Institutes of Health
Grant: 5R01CA225637-02
Mechanism of APE1 in DNA damage response
National Institutes of Health
Grant: 1R03CA270663-01A1
Mechanism of APE2 in genome integrity
National Institutes of Health
Grant: 5R21ES032966-02
ATM activation by DNA single-strand breaks
National Institutes of Health
Grant: 5R01CA251141-03
New mouse model of cisplatin-induced AKI and development of prevention therapy
National Institutes of Health
V Foundation Scholar Award
University of North Carolina at Charlotte
Case Comprehensive Cancer Center's VeloSano Program Science Award
CCF SPARK
Cancer Shark Tank Award
Global Center for Pathogen and Human Health Research Pilot
Velosano
Fields of Study
Keywords